CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Axsome Begins Phase III Study on AXS-05 for Smoking Cessation

Phase 3AXS-05Neutral
AI Analysis

Summary

Axsome Therapeutics has initiated a Phase III study evaluating AXS-05 for smoking cessation treatment.

Clinical Trial Data

Phase

Phase 3

Importance:6/10
Sentiment:
0.00
Phase 3Smoking CessationClinical TrialAXS-05
Related Companies

Read the original article

Published by yahoo_finance on September 1, 2026 4:05 PM

Read Original